Monday, February 28, 2011

The "FDA Delay Trade"

Protalix boards are debating something called the FDA Rejection/Delay Trade.
Every time there is a delay and/or rejection, buy at the open and you make 10% minimum within a few days or at most a couple weeks. MNKD, OREX, PLX, BIOD, it seems to happen every single time without exception.
Markets are known to over-react. The strategy seems reasonable. I have not sold my PLX Protalix shares. FDA wants to be sure if Protalix Carmiel plant is clean. It is in the Middle East, is it? The sewage runs on the streets, no? They wash hands with sand, do they?

4 comments:

Anonymous said...

I think the FDA is aware that Tel Aviv is not the same as Baghdad but they are very cautious in general. They have had plenty of problems with contamination in factories in the US, even those run by major pharmaceutical houses. They are not discriminating against Protalix - they give everyone a hard time. The flip side of this is that once your drug is approved it is not easy for a competitor to gain approval, so whatever you lose on this end you make back later if you win the approval lottery.

K

J said...

They are bureaucrats protecting their power and position.

Anonymous said...

The bureaucratic penalties (being called up before Congress, in the press, etc.) for approving a drug that should not have been are much greater than those for NOT approving a drug that should have been (even if this philosophy costs lives, which it does).


K

J said...

I am sure there the FDA does not discriminate: It spares no expenses to make sure that it may never be blamed for a failure. In a way, that is its mandate.